Triazolevernetzte macrocyclische Peptide

European patent · EP2564863 · Deleted

Register entry

Publication number
EP2564863
Application number
EP12174833
Kind
European patent with effect for Switzerland and Liechtenstein
Status
Deleted
Specification
Granted
Filed
Feb 25, 2008
Published
Mar 6, 2013
Granted
Aug 23, 2017
Deleted
Feb 29, 2020
Reason
Annual fee unpaid
IPC classes
C07C 271/22 (2006.01)
C07K 7/56 (2006.01)
A61K 38/00 (2006.01)
Priority
US 903073 P 23.02.2007
Divided from
EP08730678
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Sep 23, 2020

    Deleted, fee unpaid

    Published in Swissreg on 23.09.2020

  2. Aug 23, 2017

    Granted

    Published in Swissreg on 23.08.2017

Parties

Holder

Aileron Therapeutics, Inc.

281 Albany Street, Cambridge, MA 02139, US

Inventor

Nash, Huw

Concord, MA 01742, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.